-
1 Comment
Bionomics Limited is currently in a long term uptrend where the price is trading 1.4% above its 200 day moving average.
From a valuation standpoint, the stock is 1170.0% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 3269.6.
Bionomics Limited's total revenue rose by 1.2% to $102K since the same quarter in the previous year.
Its net income has increased by 99.8% to $-13K since the same quarter in the previous year.
Finally, its free cash flow fell by 853.9% to $-658K since the same quarter in the previous year.
Based on the above factors, Bionomics Limited gets an overall score of 3/5.
| ISIN | AU000000BNO5 |
|---|---|
| Exchange | AU |
| CurrencyCode | AUD |
| Sector | Healthcare |
| Industry | Biotechnology |
| Beta | 2.13 |
|---|---|
| Dividend Yield | 0.0% |
| Market Cap | 15M |
| PE Ratio | None |
| Target Price | 23 |
Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder. It also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for BNO.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
